Paul’s last? He insists that ivermectin, a drug used in rare cases in humans to treat diseases such as intestinal parasites and head lice, is not being studied as a possible treatment for patients with coronavirus. because of politics.
“The hatred for Trump has bothered these people so much that they are unwilling to study it objectively,” Paul told a group in northern Kentucky late last week. “So someone like me who’s in the middle, I can’t tell you because they won’t study ivermectin. They won’t study hydroxychloroquine without the tinge of their hatred for Donald Trump.”
To be clear: Paul is NOT in the “middle” when it comes to the use of ivermectin. He’s WAY at the end of the conspiracy theory spectrum.
(Box: This is the sort of thing the FDA shouldn’t have to say. But …)
“Throughout the pandemic, ivermectin, an antiparasitic drug, has gained a lot of attention, especially in Latin America, as a potential way to treat COVID-19. that the drug dramatically reduces deaths from COVID-19 weakens the promise of ivermectin – and highlights the challenges of investigating the drug’s effectiveness during a pandemic …
“… The article summarized the results of a clinical trial that appeared to show ivermectin can reduce COVID-19 death rates by more than 90% – among largest studies on the drug’s ability to treat COVID-19 to date. But on July 14, after Internet sleuths raised concerns about plagiarism and data manipulation, preprint server Research Square withdrew the document due to “ethical concerns. “.
“Based on the current very low to low certainty evidence, we are uncertain about the efficacy and safety of ivermectin used to treat or prevent COVID-19. The studies completed are small and few are considered to be of high quality. Several studies are underway that may produce clearer answers in journal updates. Overall, the available reliable evidence does not support the use of ivermectin for the treatment or prevention of COVID-19 outside of well-designed randomized trials.
So there have been at least 14 studies on the effectiveness of ivermectin to treat the coronavirus. Which doesn’t seem, as Paul argued, that no one is willing to study the drug because he hates Donald Trump.
Paul’s problem isn’t that ivermectin is being ignored as a potential treatment for Covid-19 patients. This is because the data, which clearly shows that there is no benefit (at least so far) to using the drug, does not match what its base wants to believe. It’s his problem, not ours.